Delivery Order SPE2DB22D3501-SPE2DB25FXA71
Award Date 8/26/25
Potential Completion Date 8/27/25
Potential Value $4.5K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $7,434.78 to AmerisourceBergen Drug Corp for the supply of Xifaxan 550 mg tablets (60-count) on August 22, 2025, with an ultimate completion date of August 25, 2025. This competitively awarded, firm fixed-price contract carries no set-aside designation and will be performed at the vendor's corporate office location in Conshohocken, Pennsylvania. Xifaxan is a gastrointestinal antibiotic commonly used to treat traveler's...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 27, 2025, for the supply of Xifaxan 550 mg tablets (60-count units) with a ceiling value of $7,597.68. This is a firm fixed-price delivery order with no set-aside designation, indicating it was awarded through open competition. The order is scheduled for ultimate completion on August 28, 2025, with performance taking place at AmerisourceBergen's corporate office location in Conshohocken,...
- The Defense Logistics Agency awarded a $43,495.06 firm fixed-price delivery order to AmerisourceBergen Drug Corp on September 3, 2025, for the supply of Xifaxan 550 mg tablets (60-count units). The contract, which represents a child award under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical, carries an ultimate completion date of September 4, 2025, and involves no set-aside designation, indicating competitive award status. Performance will be executed at...
- The Defense Logistics Agency awarded a $14.9K delivery order to AmerisourceBergen Drug Corp on August 26, 2025, for the supply of Xifaxan 550 mg tablets (60-count units). This competitively awarded, firm fixed-price contract with no set-aside designation is scheduled for completion by August 27, 2025, and will be performed at the vendor's corporate office location in Conshohocken, Pennsylvania. Xifaxan is a non-absorbed antibiotic commonly used in federal medical supply chains to support...
- The Defense Logistics Agency awarded a delivery order valued at $6,348.06 to AmerisourceBergen Drug Corp for 60-tablet bottles of Xifaxan 550 mg on August 18, 2025, with completion scheduled for August 19, 2025. This firm fixed price delivery order represents a competitive award with no set-aside designation and will be performed at the contractor's facility in Conshohocken, Pennsylvania. Xifaxan is an antibiotic used to treat traveler's diarrhea and other gastrointestinal conditions, supporting...
- The Defense Logistics Agency awarded a $9,260.88 firm fixed-price delivery order to AmerisourceBergen Drug Corp for 60-tablet units of Xifaxan 550 mg tablets, with an ultimate completion date of August 18, 2025. This non-set-aside delivery order was competitively awarded on August 15, 2025, and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. Xifaxan is a non-absorbed antibiotic commonly used in military and federal healthcare settings for...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 7, 2025, for the supply of Xifaxan 550 mg tablets (60-count units) with a ceiling value of $1,594.13. This firm fixed-price delivery order, with an ultimate completion date of August 8, 2025, is performed at AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. The award was made through competitive procedures with no set-aside designation, reflecting the contractor's demonstrated...
- The Defense Logistics Agency awarded a delivery order valued at $2,352.39 to AmerisourceBergen Drug Corp on July 18, 2025, for the supply of Xifaxan 550 mg tablets (60-count packaging). This non-set-aside, firm fixed-price delivery order is scheduled for completion by July 21, 2025, with performance occurring at the vendor's corporate office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and critical federal healthcare vendor, fulfills...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 20, 2025, for the supply of Xifaxan 550 mg tablets in quantities of 60 units, with a contract ceiling value of $1,640.75. This firm fixed-price delivery order, which is not set-aside, is scheduled for ultimate completion on August 21, 2025, and will be performed at the vendor's corporate office location in Conshohocken, Pennsylvania. The award represents a single delivery order issued under...
- The Defense Logistics Agency awarded a $10,955.02 firm fixed price delivery order to AmerisourceBergen Drug Corp for 60-count bottles of Xifaxan 550 mg tablets, with an ultimate completion date of September 19, 2025. This non-set-aside award was issued on September 18, 2025, and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. Xifaxan is a broad-spectrum antibiotic commonly used to treat traveler's diarrhea and other gastrointestinal infections,...